The association between migraine and Parkinson’s disease: a nationwide cohort study

키워드

참고문헌 (40)

1. Aguggia M, "Pathophysiology of migraine chronification", Neurol Sci, 31(Suppl 1), pp.S15~S17 (2010)[DOI]
2. Kruit MC, "Migraine as a risk factor for subclinical brain lesions", JAMA, 291, pp.427~434 (2004)[DOI]
3. Recober A, "Pathophysiology of migraine", Continuum(Minneap Minn), 27, pp.586~596 (2021)[DOI]
4. Øie LR, "Migraine and risk of stroke", J Neurol Neurosurg Psychiatry, 91, pp.593~604 (2020)[DOI]
5. Amiri S, "Migraine headache and depression in adults : a systematic review and meta-analysis", Neuropsychiatr, 33, pp.131~140 (2019)[DOI]
6. Kurt S, "The comorbidity of migraine and restless legs syndrome", Curr Neurol Neurosci Rep, 19, pp.60~ (2019)[DOI]
7. Lin GY, "Prevalence of restless legs syndrome in migraine patients with and without aura : a cross-sectional, case-controlled study", J Headache Pain, 17, pp.97~ (2016)[DOI]
8. Scher AI, "Midlife migraine and late-life parkinsonism : AGES-Reykjavik study", Neurology, 83, pp.1246~1252 (2014)[DOI]
9. Wang HI, "Migraine is related to an increased risk of Parkinson’s disease : a population-based, propensity score-matched, longitudinal follow-up study", Cephalalgia, 36, pp.1316~1323 (2016)[DOI]
10. Park JH, "Trends in the incidence and prevalence of Parkinson’s disease in Korea : a nationwide, population-based study", BMC Geriatr, 19, pp.320~ (2019)[DOI]
11. Kang SH, "Incidence of Parkinson’s disease and modifiable risk factors in Korean population : a longitudinal follow-up study of a nationwide cohort", Front Aging Neurosci, 15, pp.1094778~ (2023)[DOI]
12. Lee J, "Quality of life of caregivers of individuals with Parkinson’s disease", Rehabil Nurs, 44, pp.338~348 (2019)[DOI]
13. Roh JH, "The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease", Acta Neurol Scand, 119, pp.397~403 (2009)[DOI]
14. Thompson PD, "ACSM’s new preparticipation health screening recommendations from ACSM’s guidelines for exercise testing and prescription, ninth edition", Curr Sports Med Rep, 12, pp.215~217 (2013)
15. Yoon SY, "Association of physical activity, including amount and maintenance, with all-cause mortality in Parkinson disease", JAMA Neurol, 78, pp.1446~1453 (2021)[DOI]
16. Barbanti P, "Dopaminergic symptoms in migraine", Neurol Sci, 34(Suppl 1), pp.S67~S70 (2013)[DOI]
17. Charbit AR, "Dopamine : what’s new in migraine?", Curr Opin Neurol, 23, pp.275~281 (2010)[DOI]
18. Kruit MC, "Iron accumulation in deep brain nuclei in migraine : a population-based magnetic resonance imaging study", Cephalalgia, 29, pp.351~359 (2009)[DOI]
19. Chen Z, "The increased iron deposition of the gray matter over the whole brain in chronic migraine : an exploratory quantitative susceptibility mapping study", Mol Pain, 18, pp.17448069221074987~ (2022)[DOI]
20. Dusek P, "Iron dysregulation in movement disorders", Neurobiol Dis, 46, pp.1~18 (2012)[DOI]
21. Jurado-Coronel JC, "Sex differences in Parkinson’s disease : features on clinical symptoms, treatment outcome, sexual hormones and genetics", Front Neuroendocrinol, 50, pp.18~30 (2018)[DOI]
22. Edvinsson L, "Role of CGRP in migraine", Handb Exp Pharmacol, 255, pp.121~130 (2019)[DOI]
23. Raffaelli B, "Sex hormones and calcitonin gene-related peptide in women with migraine : a cross-sectional, matched cohort study", Neurology, 100, pp.e1825~e1835 (2023)[DOI]
24. Labastida-Ramírez A, "Gender aspects of CGRP in migraine", Cephalalgia, 39, pp.435~444 (2019)[DOI]
25. Thornton E, "Substance P and its tachykinin NK1 receptor : a novel neuroprotective target for Parkinson’s disease", Neural Regen Res, 10, pp.1403~1405 (2015)[DOI]
26. Gimeno-Ferrer F, "From spreading depolarization to epilepsy with neuroinflammation : the role of CGRP in cortex", Exp Neurol, 356, pp.114152~ (2022)[DOI]
27. Di Angelantonio S, "Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells", Br J Pharmacol, 139, pp.1061~1073 (2003)[DOI]
28. Svenningsson P, "Neuropeptide Y and calcitonin gene-related peptide in cerebrospinal fluid in Parkinson’s disease with comorbid depression versus patients with major depressive disorder", Front Psychiatry, 8, pp.102~ (2017)[DOI]
29. Hamed SA, "The vascular risk associations with migraine : relation to migraine susceptibility and progression", Atherosclerosis, 205, pp.15~22 (2009)[DOI]
30. Liampas I, "Serum lipid abnormalities in migraine : a meta-analysis of observational studies", Headache, 61, pp.44~59 (2021)[DOI]
31. Hu G, "Total cholesterol and the risk of Parkinson disease", Neurology, 70, pp.1972~1979 (2008)[DOI]
32. Nam GE, "Metabolic syndrome and risk of Parkinson disease : a nationwide cohort study", PLoS Med, 15, pp.e1002640~ (2018)[DOI]
33. Chen H, "Dietary intakes of fat and risk of Parkinson’s disease", Am J Epidemiol, 157, pp.1007~1014 (2003)[DOI]
34. Rappley I, "Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype", J Neurochem, 111, pp.15~25 (2009)[DOI]
35. Lin YK, "Pathophysiology of chronic migraine : insights from recent neuroimaging research", Curr Pain Headache Rep, 26(11), pp.843~854 (2022)[DOI]
36. Niddam DM, "Neurochemical changes in the medial wall of the brain in chronic migraine", Brain, 141, pp.377~390 (2018)[DOI]
37. PBR28 PET, "MRI study", Neurology, 92, pp.e2038~e2050 (2019)[DOI]
38. Kim KM, "Prevalence, disability, and management patterns of migraine in Korea : nationwide survey data from 2009 and 2018", J Clin Neurol, 17, pp.77~85 (2021)[DOI]
39. Russell MB, "Prevalence and sex-ratio of the subtypes of migraine", Int J Epidemiol, 24, pp.612~618 (1995)[DOI]
40. Mansournia MA, "Handling time varying confounding in observational research", BMJ, 359, pp.j4587~ (2017)[DOI]

관련 논문AI추천